Resources
85 Results (showing 1 - 10)
Results sorted by posted date (newest first)
Results sorted by posted date (newest first)
Posted 4/16/2024 (updated 4/24/2024)
Adverse childhood experiences (ACEs) are events of abuse, neglect, and household dysfunction that occur between birth and 17 years of age. Multiple studies established the association between ACEs, risky behaviors, and poor physical and mental health outcomes in childhood and beyond. Rural and minority children often have higher rates of ACEs exposure than their peers.
Posted 4/12/2024
This peer reviewed journal article OUD treatment and pregnancy outcomes among pregnant patients receiving OUD care through a telehealth addiction treatment program in the US. The patients identified in the study received buprenorphine or buprenorphine and naloxone treatment.
Posted 4/4/2024 (updated 4/18/2024)
If you or someone else is in immediate danger, call 911 to seek immediate assistance.
Below are resources you can contact if you are seeking assistance or information. All resources are intended for informational purposes only.
Posted 3/29/2024
The Centers for Disease Control and Prevention (CDC) has naloxone trainings and fact sheets available for clinicians. The trainings and fact sheets can help clinicians raise awareness about the benefits of naloxone by talking with patients and their family, friends, and caregivers.
Posted 3/10/2024 (updated 3/28/2024)
The Substance Abuse and Mental Health Services Administration's (SAMHSA) updated Overdose Prevention and Response Toolkit provides guidance to a wide range of individuals on preventing and responding to an overdose. It emphasizes harm reduction and access to treatment as essential aspects of overdose prevention.
Posted 2/20/2024 (updated 3/28/2024)
Early exposure to Adverse Childhood Experiences (ACEs), (e.g., parental substance use) increases the likelihood of future substance use and drug overdose, resulting in an intergenerational cycle of substance-related ACEs.
Posted 1/19/2024 (updated 3/28/2024)
The FDA announced that the manufacturer of NARCAN 4 mg Nasal Spray products, Emergent BioSolutions, has extended the shelf-life of their product from 3 years to 4 years. This new extension of shelf-life was requested by the FDA to help prevent overdoses and reduce overdose-related deaths.
Posted 10/23/2023 (updated 5/24/2024)
Using data from 77 harm reduction programs in 25 US states, researchers found that 12-15% of powder methamphetamine and powder cocaine also contained fentanyl although the prevalence varied geographically. Prevalence of fentanyl in crystal methamphetamine and crack cocaine was lower. Heroin and xylazine were also found in unregulated stimulants. Xylazine reduced the ability to detect fentanyl.
Posted 10/23/2023 (updated 3/27/2024)
The 2023 RCORP-CABH Onboarding Packet includes resources, tools, and strategies to support grant-funded activities, along with information on accessing TA. We hope you find the Onboarding Packet helpful as a starting point. Our TA team is here to support you through your grant, so should you have any questions related to this document or other technical assistance needs, please do not hesitate to contact your Technical Expert Lead (TEL).
Posted 10/10/2023 (updated 3/27/2024)
The University of Rochester, a RCORP-Rural Center of Excellence on SUD Prevention, has 988 Lifeline posters available for download on their website. The national 988 Suicide & Crisis Lifeline was launched in July 2023 and provides a way for individuals experiencing a suicidal, mental health, or substance use disorder crisis to receive urgent help 24/7. Spreading awareness of the 988 Lifeline is important as it can help residents in rural areas obtain treatment and help quickly.